Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05414851 · ClinicalTrials.gov registry record · NA
Low-Carbohydrate and Plant-Based Dietary Effects on Vascular Health
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT05414851: Completed NA study, sponsored by University of Rochester.
NCT05414851 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05414851, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
This is a randomized trial with a crossover design to investigate the short-term effects of two different dietary patterns on markers of vascular health. A low-carbohydrate diet and a whole-food, plant-based diet will be used. In addition to more traditional markers (cholesterol, blood pressure, inflammation), endothelial progenitor cells and trimethylamine N-oxide will be assessed.
Interventions
- OTHER Whole-Food, Plant-Based Diet and Low-Carbohydrate Diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2022-12-20 |
| Est. Completion | 2024-04-23 |
| Phase | NA |
What the finished NCT05414851 record still lists
NCT05414851 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Whole-Food, Plant-Based Diet and Low-Carbohydrate Diet is the first listed.
NCT05414851 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05414851 about?
NCT05414851 is a clinical study titled "Low-Carbohydrate and Plant-Based Dietary Effects on Vascular Health". This is a randomized trial with a crossover design to investigate the short-term effects of two different dietary patterns on markers of vascular health. A low-carbohydrate diet and a whole-food, plant-based diet will be used. In addition to more traditional markers (cholesterol, blood pressure, inf...
What is the current status of trial NCT05414851?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2022-12-20. Estimated completion is 2024-04-23.
What interventions are being tested in trial NCT05414851?
The interventions under investigation include: Whole-Food, Plant-Based Diet and Low-Carbohydrate Diet (OTHER).
Who is sponsoring clinical trial NCT05414851?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05414851's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI